Evaluation of skin cancer screening in Germany – a Microsimulation
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2025
DOI: 10.1111/ddg.15539 ↗Kurz gefasst
Fachartikel in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2025. Verfasst von Hannah Baltus und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Social Medicine and Epidemiology, Lübeck University, Lübeck, Germany. Hauptthemen laut MEDLINE: Skin Neoplasms, Computer Simulation, Early Detection of Cancer. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Innovationsfond.
Abstract (Originalsprache)
Background
Comprehensive skin cancer screening was introduced in Germany in 2008. It is unclear whether subsequently observed changes in the epidemiology of malignant melanoma (MM), squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are due to the screening. Simulation models are used to compare different screening scenarios with each other and with observed incidence and mortality trends.
Methods
A microsimulation model for MM, SCC, and BCC was programmed and validated separately by sex on skin cancer‐specific mortality data. In addition to the currently practiced screening (biennial offer, annual participation probability 15%), triennial screening, screening with increased participation, e.g., via invitation, and no screening were simulated. Incidence, mortality, costs, and life‐years gained were simulated for 30 years from the start of screening.
Results
Compared with no screening, mortality is reduced by 13.8% in the simulation with current conditions. This effect occurs in the first years after screening starts before reaching a stable level. More screening allows for further increases in incidence, life‐years gained, and costs and decreases in mortality. Comparing simulated and observed effects shows little agreement.
Conclusions
The model is useful for comparing screening scenarios to identify potential optimization opportunities in SCS. Additional, especially risk‐adapted, screening scenarios should be investigated.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Social Medicine and Epidemiology, Lübeck University, Lübeck, Germany.
- Institute of Health Services Research in Dermatology and Nursing (IVDP), University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany.
ORCID-Profile: Kristina Hagenström, Jobst Augustin, Matthias Augustin
Förderung
- Innovationsfond
Zitieren
APA
Baltus, H., Hübner, J., Garbe, C., Hagenström, K., Rohr, M., Hischke, S., Augustin, J., Augustin, M., Katalinic, A., & Eisemann, N. (2025). Evaluation of skin cancer screening in Germany – a Microsimulation. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15539
Vancouver
Baltus H, Hübner J, Garbe C, Hagenström K, Rohr M, Hischke S, et al. Evaluation of skin cancer screening in Germany – a Microsimulation. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2025. doi:10.1111/ddg.15539
BibTeX
@article{Baltus2025,
author = {Baltus, Hannah and Hübner, Joachim and Garbe, Claudia and Hagenström, Kristina and Rohr, Maren and Hischke, Sandra and Augustin, Jobst and Augustin, Matthias and Katalinic, Alexander and Eisemann, Nora},
title = {Evaluation of skin cancer screening in Germany – a Microsimulation},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2025},
doi = {10.1111/ddg.15539}
}
EUVIMED